Histological Diagnosis and Frequency of Primary Endocrine Tumors (ETs) and Neuroendocrine Tumors (NETs) According to WHO Classification

MH Bukhari; S Niazi; N Shah; M Anwar; EM Khalee; Q Samina; M Munir

International Journal of Endocrinology and Metabolism

Research Institute for Endocrine Sciences

Current Issue All Issues In Press Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Histological Diagnosis and Frequency of Primary Endocrine Tumors (ETs) and Neuroendocrine Tumors (NETs) According to WHO Classification

Author(s):

MH Bukhari^1,*,

S Niazi²,

N Shah³,

M Anwar³,

EM Khalee²,

Q Samina³,

M Munir²

1Department of Pathology King, Edward Medical University, drmhbukhari@yahoo.com, Pakistan

2Department of Pathology King, Edward Medical University, Pakistan

3Departmentof Surgery, Mofftitt Cancer Center Tampa, Japan

International Journal of Endocrinology and Metabolism:Vol. 6, issue 4; 205-214

Article type:Research Article

Received:Sep 28, 2008

Accepted:Nov 04, 2008

How to Cite:MH BukhariS NiaziN ShahM AnwarEM KhaleeQ SaminaM Muniret al.Histological Diagnosis and Frequency of Primary Endocrine Tumors (ETs) and Neuroendocrine Tumors (NETs) According to WHO Classification.Int J Endocrinol Metab.6(4):205-214.

Abstract

The new WHO classification provides the foun-dation for tumor diagnosis, patient treatment and tools for clinico-epidemiological research. This study was conducted to determine the fre-quency and update the histological aspects of different endocrine and neuroenodocrine tumors for clinical significance and to minimize unclas-sified lesions. Materials and Methods: Five hundred biopsies were analyzed in the Pathology Department of King Edward Medical University from 1st June 2004 to 31st December 2005. Tumors were diag-nosed with light microscopy using the new WHO classification. Results: Following 500 biopsies, 145 (29%) Endo-crine(ET) and Neuroendocrine Tumors (NET) were found; majority of the former, ET, n=112 (77.2%), were in the thyroid, of which 84 (75%) were follicular adenomas and 28 (25%) were carcinomas, of the 28 carcinomas, the frequencies were: papillary carcinoma (PC) 21 (75%); anaplastic(AC) 4 (14.28%); follicular(FC) 2 (7.14%); and medullary (MC) 1 (3.57%). Of the 145, 33 (22.8%) were neuroendocrine tumors (NET), with the following types and frequencies: adrenal 13 (39.5%); pituitary 10 (30.5%); pancreatic 4 (12%); parathyroid 3(9%); appendix 1 (3%); and rectum 1 (3%). One NET detected in the thyroid region was a well-differentiated neuroendocrine carcinoma (WDNEC). Among adrenal NETs, of 13 only 2 (14.4%) were malignant and diagnosed as a cortical and a neuroblastoma respectively, while all others were benign NETS, as follows: cortical adenoma 2 (15.38%); pheochromocytoma 7 (53.8%) and 1 (7.69%) ganglio neuroblastoma, and ganglioneuroma each respectively. All pituitary, parathyroid and pancreatic NETS were benign in nature. NETS of the appendix and rectum were WDNETS, while that of the lung was a WDNEC. Findings of this study confirm that the WHO classification provides uniform, simple, repro-ducible and practical criteria for diagnosis of ETs and NETS.

Keywords

Endocrine tumors

Neuroendocrine tumors

Histological classification

Full Text

Full text is available in PDF

comments